Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Eiger BioPharmaceuticals Inc | EIGR | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
1.725 | 1.725 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 1.10 - 43.35 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 1.725 | USD |
Información Financiera Eiger BioPharmaceuticals Inc EIGR
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
US$ 2.55M | - | - | - | -2.64 |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Eiger BioPharmaceuticals Inc EIGR
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
01/4/2024 | 10:12 | GlobeNewswire Inc. | Eiger BioPharmaceuticals Files for Voluntary Chapter 11.. |
11/3/2024 | 15:03 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 15:59 | Edgar (US Regulatory) | Form 8-K - Current report |
18/1/2024 | 16:49 | PR Newswire (US) | Eiger and Partner, AnGes, Receive Approval for Zokinvy®.. |
08/1/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 07:45 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 07:00 | PR Newswire (US) | Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse.. |
11/12/2023 | 15:01 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
04/12/2023 | 05:01 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
01/12/2023 | 15:02 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
24/11/2023 | 05:01 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
13/11/2023 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos EIGR
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 1.85 | 2.8798 | 1.66 | 2.20 | 395,810 | -0.125 | -6.76% |
3 Months | 6.18 | 8.2672 | 1.10 | 2.03 | 160,117 | -4.46 | -72.09% |
6 Months | 8.43 | 14.337 | 1.10 | 5.97 | 181,311 | -6.71 | -79.54% |
1 Year | 31.50 | 43.35 | 1.10 | 16.36 | 301,626 | -29.78 | -94.52% |
3 Years | 256.80 | 300.639 | 1.10 | 120.82 | 434,546 | -255.08 | -99.33% |
5 Years | 321.90 | 474.60 | 1.10 | 183.14 | 382,751 | -320.18 | -99.46% |